62 episodes

First In Human is a biotech-focused podcast that interviews industry leaders and investors to learn about their journey to in-human clinical trials. Presented by Vial, a tech-enabled CRO with episodes launching weekly on Tuesday's.🎧 Stay in the Loop!For the latest news and updates, visit our website: https://vial.comFollow us on social media for real-time insights:Twitter: https://twitter.com/VialTrialsLinkedIn: https://www.linkedin.com/company/vialtrials

First In Human By Vial Vial

    • Science
    • 5.0 • 16 Ratings

First In Human is a biotech-focused podcast that interviews industry leaders and investors to learn about their journey to in-human clinical trials. Presented by Vial, a tech-enabled CRO with episodes launching weekly on Tuesday's.🎧 Stay in the Loop!For the latest news and updates, visit our website: https://vial.comFollow us on social media for real-time insights:Twitter: https://twitter.com/VialTrialsLinkedIn: https://www.linkedin.com/company/vialtrials

    Episode 62: Josh Mandel-Brehm - CEO, CAMP4 Therapeutics

    Episode 62: Josh Mandel-Brehm - CEO, CAMP4 Therapeutics

    Explore the untapped potential of RNA amplifying therapeutics with the CEO of CAMP4 Therapeutics, Josh Mandel-Brehm. We uncover the power of antisense oligonucleotides in rewriting the narrative for genetic diseases characterized by protein deficiency. Josh takes us behind the scenes of their innovative RNA Actuating Platform (RAP), a map charting the course of gene expression and a guide to the regulatory RNAs that can turn up the volume on genes gone silent due to disease. It's a pion...

    • 20 min
    Episode 61: William Korinek - CEO and Co-Founder, Astrocyte Pharmaceuticals

    Episode 61: William Korinek - CEO and Co-Founder, Astrocyte Pharmaceuticals

    Embark on a journey through the neurons and synapses of brain science with William Korinek, the CEO of Astrocyte Pharmaceuticals. In a conversation that fuses the molecular intricacies of neuroprotection with the humanistic pursuit of medical advancement, Bill reveals his unique path from molecular biologist to biotech innovator. Together, we unravel the complexities of securing funding, the importance of strategic networking, and the scarcity of research dollars for conditions impacting mill...

    • 24 min
    Episode 60: Rachel Haines - VP of Clinical Development & Operations, Rinri Therapeutics

    Episode 60: Rachel Haines - VP of Clinical Development & Operations, Rinri Therapeutics

    In this episode, Rachel Haines from Rinri Therapeutics joins us to discuss the possibilities of cell therapy for hearing loss. Our conversation with Rachel goes beyond just scientific innovation; we also explore the potential impact of Rinri's upcoming human trials, which are based on Professor Marcelo Rivolta's groundbreaking work. By delving into the challenges and excitement of pioneering clinical trials in uncharted territory, we envision a future where natural hearing restoration could b...

    • 18 min
    Episode 59: Bas van der Baan - President & CEO, Lixte Biotechnology

    Episode 59: Bas van der Baan - President & CEO, Lixte Biotechnology

    Join as we dive deep into the world of oncology drug development with Bas van der Baan of Lixte. Discover the inspiration behind Lixte's focus on PP2A inhibitors and how this innovative approach is poised to revolutionize cancer treatment by enhancing chemotherapy and immunotherapy responses. Bas shares insights into ongoing clinical trials, regulatory considerations, and Lixte's ambitious long-term goals in expanding their impact on cancer care. Tune in to explore the cutting-edge science an...

    • 17 min
    Episode 58: Samarendra Mohanty - President & CSO, Nanoscope Therapeutics

    Episode 58: Samarendra Mohanty - President & CSO, Nanoscope Therapeutics

    Dr. Samar Mohanty, president and CSO of Nanoscope Therapeutics joins us to shed light on the revolutionary gene therapy that's giving hope to individuals with retinal degenerative diseases by pioneering a treatment that can re-sensitize the retina to detect low light levels. We open the curtains on their groundbreaking multi-characteristic opsins (MCOs), which have the potential to address all forms of retinal degeneration and restore vision in millions of visually impaired individuals.First ...

    • 16 min
    Episode 57: Rob Etherington- CEO and President at Clene Nanomedicine

    Episode 57: Rob Etherington- CEO and President at Clene Nanomedicine

    Imagine unlocking the secrets to revitalizing the brain's energy centers and turning the tide on neurodegenerative diseases. In this episode, Rob introduces us to CNM-Au8, an oral nanotherapeutic with the potential to recharge failing mitochondria. Our discussion traverses the innovative path Clene has charted, from the drug's conception to the exciting clinical trial results that highlight its capacity to enhance neurological functions and offer new hope to individuals grappling with ALS and...

    • 20 min

Customer Reviews

5.0 out of 5
16 Ratings

16 Ratings

abrar32 ,

nice podcast

i enjoyed that

Top Podcasts In Science

Hidden Brain
Hidden Brain, Shankar Vedantam
Radiolab
WNYC Studios
Something You Should Know
Mike Carruthers | OmniCast Media | Cumulus Podcast Network
StarTalk Radio
Neil deGrasse Tyson
Ologies with Alie Ward
Alie Ward
Sasquatch Chronicles
Sasquatch Chronicles - Bigfoot Encounters

You Might Also Like

Business Of Biotech
Matt Pillar
The Long Run with Luke Timmerman
Timmerman Report
The Readout Loud
STAT
Raising Health
Andreessen Horowitz
Masters of Scale
WaitWhat
Dwarkesh Podcast
Dwarkesh Patel